We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
OGE Energy
OGE
$10.2B
| $38K | 0.06% |
1,070
-5,873
| -85% | -$197K |
|
227
Outfront Media
OUT
$5.61B
| $38K | 0.06% |
1,963
-10,364
| -84% | -$197K |
|
228
PBF Energy
PBF
$7.33B
| $38K | 0.06% |
+901
| New | +$37.7K |
|
229
PG&E
PCG
$47B
| $38K | 0.06% |
883
+788
| +829% | +$34.2K |
|
230
Principal Financial Group
PFG
$23.2B
| $38K | 0.06% |
+709
| New | +$41.2K |
|
231
Philip Morris
PM
$298B
| $38K | 0.06% |
474
-2,346
| -83% | -$199K |
|
232
Phillips 66
PSX
$83B
| $38K | 0.06% |
+342
| New | +$38.4K |
|
233
Rockwell Automation
ROK
$51.3B
| $38K | 0.06% |
227
-2,208
| -91% | -$384K |
|
234
Roper Technologies
ROP
$35.1B
| $38K | 0.06% |
139
-569
| -80% | -$157K |
|
235
Revvity
RVTY
$12.6B
| $38K | 0.06% |
+518
| New | +$38.9K |
|
236
Starbucks
SBUX
$118B
| $38K | 0.06% |
770
-2,777
| -78% | -$158K |
|
237
Teradata
TDC
$2.6B
| $38K | 0.06% |
+947
| New | +$38.1K |
|
238
UGI
UGI
$7.92B
| $38K | 0.06% |
721
-5,112
| -88% | -$248K |
|
239
Union Pacific
UNP
$181B
| $38K | 0.06% |
268
+266
| +13,300% | +$37.1K |
|
240
Veeva Systems
VEEV
$29.2B
| $38K | 0.06% |
+497
| New | +$37.8K |
|
|
WCC
241
WESCO International
WCC
$16.1B
| $38K | 0.06% |
657
+346
| +111% | +$21K |
|
242
Willis Towers Watson
WTW
$27.2B
| $38K | 0.06% |
249
-2,682
| -92% | -$408K |
|
|
NUAN
243
DELISTED
Nuance Communications, Inc.
NUAN
| $38K | 0.06% |
3,127
-13,120
| -81% | -$163K |
|
244
Abbott
ABT
$175B
| $37K | 0.06% |
612
-3,130
| -84% | -$190K |
|
245
Aecom
ACM
$8.69B
| $37K | 0.06% |
+1,129
| New | +$38.7K |
|
246
Aptiv
APTV
$11.9B
| $37K | 0.06% |
+408
| New | +$38K |
|
247
Aramark
ARMK
$15B
| $37K | 0.06% |
1,393
-29
| -2% | -$802 |
|
248
Baxter International
BAX
$11.2B
| $37K | 0.06% |
507
-724
| -59% | -$51K |
|
249
Bright Horizons
BFAM
$3.91B
| $37K | 0.06% |
+365
| New | +$36.7K |
|
250
BorgWarner
BWA
$13.2B
| $37K | 0.06% |
+984
| New | +$43.4K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.